EyePoint (EYPT) Operating Income Growth (1y) (2011 - 2026)
EyePoint (EYPT) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn | 1,386.07% |
| 10 | EyePoint | 1.06 Mn | -221.48 Mn | 168,000.00 | -78.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.61% |
| Dec 31, 2025 | -55.50% |
| Sep 30, 2025 | -89.40% |
| Jun 30, 2025 | -80.13% |
| Mar 31, 2025 | -46.57% |
| Dec 31, 2024 | -176.62% |
| Sep 30, 2024 | -127.45% |
| Jun 30, 2024 | -51.78% |
| Mar 31, 2024 | -54.59% |
| Dec 31, 2023 | 62.61% |
| Sep 30, 2023 | 21.74% |
| Jun 30, 2023 | -18.45% |
| Mar 31, 2023 | -17.88% |
| Dec 31, 2022 | -142.30% |
| Sep 30, 2022 | -20.15% |
| Jun 30, 2022 | -75.03% |
| Mar 31, 2022 | -67.21% |
| Dec 31, 2021 | -41.71% |
| Sep 30, 2021 | -682.47% |
| Jun 30, 2021 | 1.55% |